Factors associated with serum alanine transaminase activity in healthy subjects: Consequences for the definition of normal values, for selection of blood donors, and for patients with chronic hepatitis C

Hepatology

Volumn 27, Issue 5, 1998, Pages 1213-1219

  Piton, Annie ^e   Poynard, Thierry ^a,i   Imbert Bismut, Françoise ^e   Khalil, Lina ^h   Delattre, Jacques ^e   Pelissier, Elisabeth ^h   Sansonetti, Nicole ^h   Opolon, Pierre ^a   Benhamou, Yves ^a   Mathurin, Philippe ^a   Moussali, Joseph ^a   Ratziu, Vlad ^a   Sobetski, Rodolphe ^a   Bernard, Brigitte ^a   Nguyen, Eric ^a   Chollet, Robert ^a   Blot, Cecile ^a   Perrin, Michèle ^a   Cacoub, Patrice ^b   Charlotte, Frederic ^c   Charpentier, Yves Le ^c   Thibault, Vincent ^d   Agut, Henri ^d   Huraux, Jean Marie ^d   Musset, Lucile ^f   Costa, Jean Marc ^g   Olivi, Martine ^g   Sajus, Marc ^g   Vidaud, Michel ^g   Deckmin, Olivier ^h   Vidaud, Jean René ^h   more..

^a INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

^b Service de MéDecine Interne   (France)

^c Service d'Anatomie Pathologique   (France)

^d Service de Virologie   (France)

^e Service de Biochimie   (France)

^f Service d'Immuno Biochimie

^g CNRS   (France)

^h France Teaser ^*

ⁱ PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BLOOD DONOR; CHRONIC HEPATITIS; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HEPATITIS C; HUMAN; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; NORMAL VALUE; PRIORITY JOURNAL;

ADULT; AGE FACTORS; ALANINE TRANSAMINASE; ALCOHOL DRINKING; BLOOD DONORS; BODY MASS INDEX; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INTERFERONS; MALE; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; QUESTIONNAIRES; REGRESSION ANALYSIS; SEX FACTORS; SMOKING;

EID: 17344363641     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510270505     Document Type: Article

References (16)

1. Mathurin P, Moussalli J, Cadranel J-F, Thibault V, Charlotte F, Durouchel P, Cazier A, et al. Slow progression rate of fibrosis in HCV patients with persistently normal ALT activity. HEPATOLOGY 1998;27:868-872.
2. Serfaty L, Chazouilleres O, Pawlotsky JM, Andreani T, Pellet C, Poupon R. Interferon alfa therapy in patients with chronic hepatitis C and persistently normal aminotransferase activity. Gastroenterology 1996;110:291-295.
3. Poynard T, Leroy V, Cohard M, Thevenot T, Mathurin P, Opolon P, Zarski JP, et al. Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration. HEPATOLOGY 1996;24:778-789.
4. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 1997;349:825-832.
5. Anonymous. Mode de calcul du seuil d'exclusion des donneurs. Journal Officiel de la Republique Francaise 1995;31 Janvier:VI 4.7.2.
6. Mueller PW, Phillips DL, Steinberg KK. Alanine aminopeptidase in serum: automated optimized assay, and effects of age, sex, smoking, and alcohol consumption in a selected population. Clin Chem 1987;22:363-366.
7. Wejstal R, Hansson G, Lindholm A, Norkrans G. Persistent alanine aminotransferase elevation in healthy Swedish blood donors mainly caused by obesity. Vox Sang 1988;55:151-156.
8. Robinson D, Whitehead T. Effects of body mass and other factors on serum liver enzyme levels in men attending for well population screening. Ann Clin Biochem 1989;26:393-400.
9. Salvaggio A, Periti M, Miano L, Tavanelli M, Marzorati D. Body mass index and liver enzyme activity in serum. Clin Chem 1991;37:720-723.
10. Anderson T, Chrisoffersen P, Gluud C. The liver in consecutive patients with morbid obesity: a clinical morphological and biochemical study. Int J Obes 1984;8:87-106.
11. Anderson T, Gluud C. Liver morphology in morbid obesity: a literature study. Int J Obes 1984;8:97-106.
12. Manes J, Taylor H, Starkloff G. Relationship between hepatic morphology and clinical and biochemical findings in morbidly obese patients. J Clin Pathol 1973;26:776-783.
13. Moirand B, Mortaji AM, Loreal O, Paillard F, Brissot P, Deugnier Y. A new syndrome of liver iron overload with normal transferrin saturation. Lancet 1997;349:95-97.
14. Whitehead T, Robinson D, Allaway S. The effects of cigarette smoking and alcohol consumption on serum liver enzyme activities: a dose-related study in men. Ann Clin Biochem 1996;33:530-535.
15. Briere R. Effect of sex, race, and obesity on unit rejection rate. Transfusion 1989;28:392-393.
16. Carbonell N, Thiers V, Charlotte F, Pol S, Perrin M, Thibault V, AIT Arroub Z, et al. Hepatites chroniques non-A-B-C: histoire naturelle, prévalence du VHG. Strasbourg: Journées Francophones de Pathologie Digestive. Gastroenterol Clin Biol 1997;21:A195.